RESEARCHER PROFILE
Donald J. Buchsbaum
← Back to University of Alabama at Birmingham
D
University of Alabama at Birmingham
Donald J. Buchsbaum works in Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Pancreatic and Hepatic Oncology Research, Cell death mechanisms and regulation, Virus-based gene therapy research. Recorded institutional associations include University of Alabama at Birmingham.
478Publications
11,745Citations
56H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The Wnt/β-catenin pathway in ovarian cancer: A review
2013 · 457 citationsMulti-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 · 364 citationsDifferential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.
1998 · 346 citationsEnhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.
2000 · 218 citations18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography
1991 · 214 citationsThe Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-3
2005 · 209 citationsA Targetable, Injectable Adenoviral Vector for Selective Gene Delivery to Pulmonary Endothelium in Vivo
2000 · 203 citationsRecurrent read-through fusion transcripts in breast cancer
2014 · 181 citationsExpression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
2016 · 169 citationsST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines
2013 · 164 citationsThe Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
2016 · 164 citationsInhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
2014 · 161 citationsSynergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway
2003 · 159 citationsImmunohistochemistry in the evaluation of neovascularization in tumor xenografts
2008 · 158 citationsCombined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation
1999 · 152 citationsCellular Model of Warburg Effect Identifies Tumor Promoting Function of UCP2 in Breast Cancer and Its Suppression by Genipin
2011 · 147 citationsNoninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re.
2000 · 144 citationsAntitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
2003 · 140 citationsRationales, evidence, and design considerations for fractionated radioimmunotherapy
2002 · 129 citationsAn Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene Expression
2001 · 125 citationsIntratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
2002 · 115 citationsRNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long‐term survival and reveals a role forANGPTL4
2016 · 114 citationsPolyethylene Glycosylated Curcumin Conjugate Inhibits Pancreatic Cancer Cell Growth through Inactivation of Jab1
2009 · 113 citationsTreatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation
2002 · 111 citationsCatalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers
2013 · 101 citations
